230 related articles for article (PubMed ID: 20660298)
1. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis.
Roussel-Gervais A; Bilodeau S; Vallette S; Berthelet F; Lacroix A; Figarella-Branger D; Brue T; Drouin J
Mol Endocrinol; 2010 Sep; 24(9):1835-45. PubMed ID: 20660298
[TBL] [Abstract][Full Text] [Related]
2. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
3. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
[TBL] [Abstract][Full Text] [Related]
4. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
Bilodeau S; Roussel-Gervais A; Drouin J
Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
[TBL] [Abstract][Full Text] [Related]
5. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.
Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ
Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
8. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
9. Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.
Weigand I; Knobloch L; Flitsch J; Saeger W; Monoranu CM; Höfner K; Herterich S; Rotermund R; Ronchi CL; Buchfelder M; Glatzel M; Hagel C; Fassnacht M; Deutschbein T; Sbiera S
J Clin Endocrinol Metab; 2019 Jul; 104(7):2535-2546. PubMed ID: 30844069
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle dysregulation in pituitary oncogenesis.
Muşat M; Vax VV; Borboli N; Gueorguiev M; Bonner S; Korbonits M; Grossman AB
Front Horm Res; 2004; 32():34-62. PubMed ID: 15281339
[TBL] [Abstract][Full Text] [Related]
12. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.
Bilodeau S; Vallette-Kasic S; Gauthier Y; Figarella-Branger D; Brue T; Berthelet F; Lacroix A; Batista D; Stratakis C; Hanson J; Meij B; Drouin J
Genes Dev; 2006 Oct; 20(20):2871-86. PubMed ID: 17043312
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.
Hewedi IH; Osman WM; El Mahdy MM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):171-9. PubMed ID: 22776845
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
15. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
16. P27/CDKN1B Translational Regulators in Pituitary Tumorigenesis.
Martins CS; Camargo RC; Saggioro FP; Neder L; Machado HR; Moreira AC; de Castro M
Horm Metab Res; 2016 Dec; 48(12):840-846. PubMed ID: 27824399
[TBL] [Abstract][Full Text] [Related]
17. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells.
Liu W; Asa SL; Ezzat S
Brain Pathol; 2002 Oct; 12(4):412-9. PubMed ID: 12408227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
